BIOMAT Database Logo BIOMAT Database Logo

Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines. 1989

C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Treatment of cancer cells with interferons can modulate expression of cell surface antigens, particularly those of the major histocompatibility complex (MHC). To examine the effect of recombinant gamma- and alpha-interferons on expression of non-MHC antigens, murine monoclonal antibodies have been used to quantitate 14 distinct tumor-associated cell surface antigens from five breast cancer cell lines and five ovarian cancer cell lines using a live cell radioimmunoassay. Both Class I and Class II MHC antigens could be augmented or induced with gamma-interferon. Significantly increased expression of MHC antigens was observed in nine of 10 cell lines with induction indices as high as 11-fold. When 17 non-MHC epitopes were measured on 10 cell lines, minimal (1.3-2.7-fold) induction was observed in 10 of the 170 instances evaluated. Expression of only two epitopes, 2G3 and 735B11, was increased on more than one cell line. On six cell lines expression of non-MHC epitopes could not be increased. Consequently, among many different cell surface determinants, interferons produced a highly selective augmentation or induction of MHC antigens, whereas augmentation or induction of other tumor-associated antigens was apparently restricted to a few epitopes.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008285 Major Histocompatibility Complex The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Complex,Complex, Histocompatibility,Complex, Major Histocompatibility,Complices, Histocompatibility,Complices, Major Histocompatibility,Histocompatibility Complex, Major,Histocompatibility Complices,Histocompatibility Complices, Major,Major Histocompatibility Complices
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D005805 Genes, MHC Class I Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man. Class I Genes,Genes, Class I,Genes, H-2 Class I,Genes, HLA Class I,MHC Class I Genes,H-2 Class I Genes,HLA Class I Genes,Class I Gene,Gene, Class I,Genes, H 2 Class I,H 2 Class I Genes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
[Association of major histocompatibility complex antigens (HLA antigens) and breast carcinoma].
December 1986, Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells.
February 1987, Journal of cellular physiology,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer lines.
January 1987, International journal of immunopharmacology,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
April 1986, Journal of immunology (Baltimore, Md. : 1950),
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Induction of MHC antigens by tumour cell lines in response to interferons.
January 1992, European journal of cancer (Oxford, England : 1990),
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Immune induction of major histocompatibility complex antigens on a human thyroid cell line (SGHTL-34).
May 1989, Journal of molecular endocrinology,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Antibodies to major histocompatibility antigens produced by hybrid cell lines.
April 1977, Nature,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
December 1988, Journal of the American Academy of Dermatology,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
January 1986, The Journal of molecular and cellular immunology : JMCI,
C M Boyer, and D V Dawson, and S E Neal, and L F Winchell, and D S Leslie, and D Ring, and R C Bast
Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
April 2009, Cancer immunology, immunotherapy : CII,
Copied contents to your clipboard!